Payment overview · 2025
General Payments
1 reported records · 1 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Family Medicine · EPHRATA, PA · NPI 1063522050
Verified facts
CMS Open Payments records show Joseph J Irwin, MD received $17.69 in general payments during 2025 across 1 reported records.
Amgen Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
1 reported records · 1 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $17.69 | 100.0% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Education | $17.69 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $17.69 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 616 | 162 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 594 | 162 |
| Levothyroxine Sodium | Levothyroxine Sodium | 536 | 122 |
| Amlodipine Besylate | Amlodipine Besylate | 416 | 113 |
| Metoprolol Succinate | Metoprolol Succinate | 284 | 75 |
| Losartan Potassium | Losartan Potassium | 274 | 78 |
| Pantoprazole Sodium | Pantoprazole Sodium | 258 | 72 |
| Meloxicam | Meloxicam | 247 | 87 |
| Metformin Hcl | Metformin Hcl | 236 | 61 |
| Famotidine | Famotidine | 231 | 55 |
| Carvedilol | Carvedilol | 219 | 51 |
| Hydrochlorothiazide | Hydrochlorothiazide | 216 | 58 |
| Lisinopril | Lisinopril | 208 | 55 |
| Furosemide | Furosemide | 193 | 53 |
| Eliquis | Apixaban | 172 | 38 |
| Metformin Hcl Er | Metformin Hcl | 166 | 47 |
| Metoprolol Tartrate | Metoprolol Tartrate | 165 | 45 |
| Mirtazapine | Mirtazapine | 165 | 39 |
| Gabapentin | Gabapentin | 157 | 43 |
| Potassium Chloride | Potassium Chloride | 157 | 39 |
| Alendronate Sodium | Alendronate Sodium | 154 | 44 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 148 | 39 |
| Tamsulosin Hcl | Tamsulosin Hcl | 145 | 39 |
| Escitalopram Oxalate | Escitalopram Oxalate | 129 | 33 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 128 | 53 |
| Clonazepam | Clonazepam | 108 | 17 |
| Clopidogrel | Clopidogrel Bisulfate | 108 | 22 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 107 | 18 |
| Duloxetine Hcl | Duloxetine Hcl | 103 | 23 |
| Spironolactone | Spironolactone | 102 | 29 |
| Xarelto | Rivaroxaban | 102 | 18 |
| Allopurinol | Allopurinol | 100 | 26 |
| Valsartan | Valsartan | 100 | 34 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 98 | 24 |
| Montelukast Sodium | Montelukast Sodium | 95 | 31 |
| Omeprazole | Omeprazole | 95 | 32 |
| Simvastatin | Simvastatin | 94 | 27 |
| Buspirone Hcl | Buspirone Hcl | 91 | 26 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 90 | 21 |
| Azithromycin | Azithromycin | 86 | 74 |
| Prednisone | Prednisone | 86 | 43 |
| Synthroid | Levothyroxine Sodium | 86 | 22 |
| Tramadol Hcl | Tramadol Hcl | 84 | 22 |
| Hydralazine Hcl | Hydralazine Hcl | 79 | 18 |
| Pioglitazone Hcl | Pioglitazone Hcl | 77 | 20 |
| Ropinirole Hcl | Ropinirole Hcl | 74 | 13 |
| Pregabalin | Pregabalin | 73 | 17 |
| Bupropion Xl | Bupropion Hcl | 72 | 21 |
| Sertraline Hcl | Sertraline Hcl | 71 | 20 |
| Ozempic | Semaglutide | 67 | 12 |
| Quetiapine Fumarate | Quetiapine Fumarate | 63 | 19 |
| Celecoxib | Celecoxib | 62 | 19 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 62 | 23 |
| Atenolol | Atenolol | 60 | 13 |
| Fluticasone Propionate | Fluticasone Propionate | 59 | 19 |
| Ramipril | Ramipril | 57 | 15 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 57 | 12 |
| Trazodone Hcl | Trazodone Hcl | 56 | 18 |
| Finasteride | Finasteride | 54 | 13 |
| Oxycodone Hcl | Oxycodone Hcl | 53 | suppressed |
| Ezetimibe | Ezetimibe | 52 | 18 |
| Januvia | Sitagliptin Phosphate | 50 | suppressed |
| Jardiance | Empagliflozin | 50 | 15 |
| Alprazolam | Alprazolam | 49 | suppressed |
| Glipizide | Glipizide | 49 | 13 |
| Baclofen | Baclofen | 48 | 16 |
| Cephalexin | Cephalexin | 46 | 30 |
| Benazepril Hcl | Benazepril Hcl | 45 | 11 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 45 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 44 | 12 |
| Novolog Flexpen | Insulin Aspart | 43 | 11 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 40 | 11 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 39 | 29 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 39 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 38 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 36 | 26 |
| Invokana | Canagliflozin | 33 | suppressed |
| Mounjaro | Tirzepatide | 33 | 11 |
| Methylprednisolone | Methylprednisolone | 32 | 28 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 32 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 32 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 31 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 30 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 30 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 30 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 30 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 30 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 28 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 28 | suppressed |
| Ondansetron Odt | Ondansetron | 28 | 14 |
| Memantine Hcl | Memantine Hcl | 27 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 27 | suppressed |
| Irbesartan | Irbesartan | 26 | suppressed |
| Lorazepam | Lorazepam | 26 | 11 |
| Pravastatin Sodium | Pravastatin Sodium | 26 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 25 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 25 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 24 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 24 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 23 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Rivastigmine | Rivastigmine | 23 | suppressed |
| Topiramate | Topiramate | 23 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 22 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 21 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 21 | suppressed |
| Sotalol | Sotalol Hcl | 21 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 20 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 20 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 19 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 19 | suppressed |
| Levofloxacin | Levofloxacin | 19 | 15 |
| Meclizine Hcl | Meclizine Hcl | 19 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 18 | 16 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 18 | 16 |
| Flecainide Acetate | Flecainide Acetate | 18 | suppressed |
| Tradjenta | Linagliptin | 18 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 17 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 17 | suppressed |
| Oxycontin | Oxycodone Hcl | 17 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 17 | 17 |
| Torsemide | Torsemide | 17 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 16 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 16 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 16 | suppressed |
| Fluconazole | Fluconazole | 16 | 13 |
| Terazosin Hcl | Terazosin Hcl | 16 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 15 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Olanzapine | Olanzapine | 15 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 14 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 14 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 14 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 14 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 14 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 13 | suppressed |
| Bumetanide | Bumetanide | 13 | suppressed |
| Chlorthalidone | Chlorthalidone | 13 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 13 | suppressed |
| Glipizide Er | Glipizide | 13 | suppressed |
| Hydrocortisone | Hydrocortisone | 13 | suppressed |
| Minoxidil | Minoxidil | 13 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 13 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 13 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 12 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 12 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 12 | suppressed |
| Klor-Con M10 | Potassium Chloride | 12 | suppressed |
| Klor-Con M20 | Potassium Chloride | 12 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 12 | suppressed |
| Risperidone | Risperidone | 12 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 12 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 12 | suppressed |
| Temazepam | Temazepam | 12 | suppressed |
| Levemir Flexpen | Insulin Detemir | 11 | suppressed |
| Levetiracetam | Levetiracetam | 11 | suppressed |
| Metronidazole | Metronidazole | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $17.69 · 1 records | Amgen Inc. | EVENITY | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error